Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Ashley Hall > Profile

Ashley Hall

Affiliations

  • Chief Development Officer at Structure Therapeutics Inc. (GPCR), 2024-09-20
  • Chief Development Officer at Reneo Pharmaceuticals Inc. (RPHM), 2023-08-29
  • Chief Development Officer at Esperion Therapeutics Inc. (ESPR), 2021-01-29
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Reneo Pharmaceuticals Inc.
 RPHM $6.28 15,625 Officer 39,600 2023-08-28 Filing